922
Views
112
CrossRef citations to date
0
Altmetric
Review Article

Crohn’s disease and the mycobacterioses: A quarter century later. Causation or simple association?

, , &
Pages 52-93 | Received 17 Sep 2011, Accepted 02 Nov 2011, Published online: 14 Jan 2012
 

Abstract

It has been more than 25 years since Mycobacterium paratuberculosis was first proposed as an etiologic agent in Crohn’s disease based on the isolation of this organism from several patients. Since that time, a great deal of information has been accumulated that clearly establishes an association between M. paratuberculosis and Crohn’s disease. However, data are conflicting and difficult to interpret and the field has become divided into committed advocates and confirmed skeptics. This review is an attempt to provide a thorough and objective summary of current knowledge from both basic and clinical research from the views and interpretations of both the antagonists and proponents. The reader is left to draw his or her own conclusions related to the validity of the issues and claims made by the opposing views and data interpretations. Whether M. paratuberculosis is a causative agent in some cases or simply represents an incidental association remains a controversial topic, but current evidence suggests that the notion should not be so readily dismissed. Remaining questions that need to be addressed in defining the role of M. paratuberculosis in Crohn’s disease and future implications are discussed.

Acknowledgments

Supported in part by the Texas Tech University Health Sciences Center and the Lizanell and Colbert Coldwell Foundation.

Declaration of interest

The authors report no declarations of interest.

Notes

1 The official name of this organism is Mycobacterium avium subspecies paratuberculosis, commonly abbreviated as MAP. The authors prefer the original approved name which more accurately reflects its’ clinical significance and phenotypic properties.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.